Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 46.1B | 48.3B | 48.9B | 49.6B |
Cost of revenue | 32.7B | 35.1B | 34.7B | 34.9B |
Gross profit | 13.4B | 13.2B | 14.3B | 14.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.2B | 1.6B | 1.2B | 1.0B |
Other operating expenses | 6.6B | 8.1B | 6.8B | 6.9B |
Operating income | 4.3B | 2.4B | 5.0B | 5.6B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 212M | 199M | 164M | 113M |
Other income expense | 1.5B | 3.8B | 1.7B | 1.6B |
Pretax income | 5.6B | 6.1B | 6.5B | 7.0B |
Tax provision | 2.1B | 2.8B | 2.0B | 2.6B |
Net income | 3.5B | 3.3B | 4.5B | 4.4B |
Basic EPS | 2.0 | 1.9 | 2.5 | 2.4 |
Diluted EPS | 2 | 1.8 | 2.5 | 2.4 |
Basic average shares | 2.0B | 2.0B | 2.0B | 2.0B |
Diluted average shares | 2.0B | 2.0B | 2.0B | 2.1B |
EBITDA | 10.0B | 10.3B | 10.9B | 11.3B |
Net income from continuing op. | 3.5B | 3.3B | 4.5B | 4.4B |
Minority interests | -12M | -20M | -9M | -9M |
Preferred stock dividends | — | — | — | — |